The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

A fascinating deep dive into the discovery, use and implications of a revolutionary new treatment ...

DCGI approval to Sun Pharma comes amid an ongoing patent dispute with Novo Nordisk in the Delhi High Court. The case relates ...

Sun Pharma receives DCGI approval to market generic semaglutide injection for chronic weight management in India. Launch after patent expiry.

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

Experts say a lack of guidance for people using the new generation of weight loss drugs like Ozempic, Wegovy and Mounjaro ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight management as an adjunct to a reduced-calorie diet and increased physical activity.

A recent report estimates that major US carriers could collectively save up to $580 million annually, thanks to the weight loss drugs ...

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...